To evaluate helical tomotherapy for the treatment of complex-shaped uni- or multifocal meningiomas.
Methods and materials
Between 2007 and 2009, 12 patients with complex-shaped meningiomas and/or multiple meningioma lesions were treated with helical tomotherapy. Histologic classification according to the most recent WHO classification for brain tumors was WHO grade I meningioma in 5 patients, atypical WHO grade II meningioma in 5 patients, and anaplastic WHO grade III meningioma in 2 patients. Eight patients were treated with primary radiotherapy, and in 4 patients tomotherapy was performed as re-irradiation for recurrent tumors.
Results
All patients were alive at the time of this analysis. Treatment was well tolerated by all patients. No severe side effects were observed. Four of 12 patients developed progression during follow-up at 2, 4, 17 and 29 months after radiotherapy. Of these, 2 patients were diagnosed with anaplastic meningiomas, and 2 patients suffered from atypical meningioma. Tumor progression developed after primary radiotherapy in 2 patients, and 2 recurrences developed after re-irradiation.
Conclusions
Helical tomotherapy can help meet the challenge of treating complex-shaped meningiomas in critical locations with one or multiple lesions due to the excellent dose distributions and the favorable clinical results.
Milker-ZabelS., ZabelA., Schulz-ErtnerD., SchlegelW., WannenmacherM., DebusJ.: Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.Int J Radiat Oncol Biol Phys, 61: 809–816, 2005.
2.
Milker-ZabelS., Zabel-duB.A., HuberP., SchlegelW., DebusJ.: Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution.Int J Radiat Oncol Biol Phys, 68: 858–863, 2007.
3.
DebusJ., WuendrichM., PirzkallA., HoessA., SchlegelW., ZunaI., Engenhart-CabillicR., WannenmacherM.: High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results.J Clin Oncol, 19: 3547–3553, 2001.
WiebeS., MunozD.G., SmithS., LeeD.H.: Meningioangiomatosis. A comprehensive analysis of clinical and laboratory features.Brain, 122(Pt 4): 709–726, 1999.
6.
GutmannD.H.: The neurofibromatoses: when less is more.Hum Mol Genet, 10: 747–755, 2001.
7.
PollackI.F., MulvihillJ.J.: Neurofibromatosis 1 and 2.Brain Pathol, 7: 823–836, 1997.
8.
SterzingF., HerfarthK., DebusJ.: IGRT with helical tomotherapy — effort and benefit in clinical routine.Strahlenther Onkol, 183 Spec No2: 35–37, 2007.
9.
SterzingF., Sroka-PerezG., SchubertK., MunterM.W., ThiekeC., HuberP., DebusJ., HerfarthK.K.: Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.Radiother Oncol, 86: 251–257, 2008.
10.
SterzingF., SchubertK., Sroka-PerezG., KalzJ., DebusJ., HerfarthK.: Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.Strahlenther Onkol, 184: 8–14, 2008.
11.
BaumertB.G., NortonI.A., DavisJ.B.: Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base.Int J Radiat Oncol Biol Phys, 57: 580–592, 2003.
12.
BaumertB.G., NortonI.A., LomaxA.J., DavisJ.B.: Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.Int J Radiat Oncol Biol Phys, 60: 1314–1324, 2004.
13.
TomeW.A., MeeksS.L., BuattiJ.M., BovaF.J., FriedmanW.A., LiZ.: A high-precision system for conformal intracranial radiotherapy.Int J Radiat Oncol Biol Phys, 47: 1137–1143, 2000.
SoissonE.T., TomeW.A., RichardsG.M., MehtaM.P.: Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.Radiother Oncol, 78: 313–321, 2006.
16.
GoldsmithB.J., WaraW.M., WilsonC.B., LarsonD.A.: Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.J Neurosurg, 80: 195–201, 1994.
17.
HugE.B., DevriesA., ThorntonA.F., MunzenrideJ.E., PardoF.S., Hedley-WhyteE.T., BussiereM.R., OjemannR.: Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.J Neurooncol, 48: 151–160, 2000.
18.
MilosevicM.F., FrostP.J., LaperriereN.J., WongC.S., SimpsonW.J.: Radiotherapy for atypical or malignant intracranial meningioma.Int J Radiat Oncol Biol Phys, 34: 817–822, 1996.
19.
GoldsmithB.J., RosenthalS.A., WaraW.M., LarsonD.A.: Optic neuropathy after irradiation of meningioma.Radiology, 185: 71–76, 1992.
20.
AndrewsD.W., FaroozanR., YangB.P., HudesR.S., Werner-WasikM., KimS.M., SergottR.C., SavinoP.J., ShieldsJ., ShieldsC., DownesM.B., SimeoneF.A., GoldmanH.W., CurranW.J.Jr.: Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery.Neurosurgery, 51: 890–902, 2002.
21.
ParsonsJ.T., FitzgeraldC.R., HoodC.I., EllingwoodK.E., BovaF.J., MillionR.R.: The effects of irradiation on the eye and optic nerve.Int J Radiat Oncol Biol Phys, 9: 609–622, 1983.
22.
ParsonsJ.T., BovaF.J., FitzgeraldC.R., MendenhallW.M., MillionR.R.: Severe dry-eye syndrome following external beam irradiation.Int J Radiat Oncol Biol Phys, 30: 775–780, 1994.
